ABLD

ABACUS FCF REAL ASSETS LEADERS

Bullish Trend

Near 52W High

$33.08+$0.03 (+0.09%)

Loading Chart...

Institutional Signal // Day Trade Edge:Neutral / No Active Setup Today

Key Statistics

Forward P/E—

52-Week Return+13.72%

50-Day Moving Avg$31.11

200-Day Moving Avg$31.06

Volume Today21.73K

Avg Volume20.89K

Day Range$32.86 – $33.12

52-Week Range$27.86 – $34.09

Open Price$32.89

Previous Close$33.05

Company Profile

No profile description available.

Exchange Listing

ABLD

Key Statistics

Company Profile

Company Profile

Recent News

Recent News

Company Profile

Recent News

ABLD

Key Statistics

Company Profile

Company Profile

Recent News

ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents

ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital

ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris

ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL

ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital

ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations

ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold

ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France

Recent News

Company Profile

Recent News

ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of Preparatory Documents

ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Number of Shares Constituting the Share Capital

ABL Diagnostics - Proposed Transfer of the Listing of Its Securities From the Regulated Market of Euronext Paris to Euronext Growth Paris

ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL

ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital

ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL’s Operations

ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold

ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France